Glenn Whelan is a seasoned professional in the field of clinical development and medical affairs, currently serving as a Clinical Development Consultant at GSK since September 2024. Whelan has held notable positions, including Senior Director of Clinical Development at Aiolos Bio, and Medical Director for Global Medical Affairs - Respiratory Biologics at GSK, where responsibilities included leading initiatives in the respiratory pipeline. Previous experience involves roles at AstraZeneca as a Senior Medical Science Liaison and Global Medical Affairs Lead, as well as significant contributions to early-phase clinical trial design at Genentech. Whelan's diverse background includes a role as Medical Science Liaison at CSL Behring, faculty positions at the University of South Florida, and consulting roles in both clinical and marketing capacities. Whelan earned a Pharm.D. from the University of Florida and has dedicated over 15 years to advancing respiratory and immunology therapeutics.